The introduction of highly active antiretroviral therapy (ART) has deeply modified the
outcome of HIV patients by improving their overall survival and ameliorating their quality of …

Malignancies represent a major cause of morbidity and mortality in human
immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral …

The optimal antiretroviral therapy (ART) regimen for human immunodeficiency virus (HIV)–
infected patients with cancer remains unknown, as clinical trials are lacking and published …

The oncology patient with HIV infection presents unique problems and challenges. When
considering antineoplastic chemotherapy, a balance must be struck between the therapeutic …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

ABSTRACT Introduction: The introduction of Highly Active Antiretroviral Therapy (HAART)
into clinical practice has dramatically changed the outcome of HIV-infected patients by …

The outcome for HIV-infected patients with cancer has dramatically improved in the highly
active antiretroviral therapy (HAART) era, probably due to improvements in immune status …

Cancer has been linked with AIDS from the earliest reports, with clusters of Kaposi's
sarcoma (KS) cases in young homosexual men being one of the first clues to the emergence …

The continued expansion of the HIV epidemic has been accompanied by a corresponding
increase in the diagnosis of malignancies in HTV-infected individuals. A direct, causal …

Antiretroviral therapy (ART) has significantly reduced morbidity and increased life
expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently …